Transcatheter tricuspid valve-in-valve in patents with transvalvular device leads

Mackram Eleid, Samuel J Asirvatham, Allison K. Cabalka, Donald J. Hagler, Peter Noseworthy, Nathaniel W. Taggart, Charanjit Rihal

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: To describe the effects of percutaneously implanted valve-in-valve in the tricuspid position for patients with pre-existing transvalvular device leads. Methods: In this case series, we describe implantation of the Melody valve and SAPIEN XT valve within dysfunctional bioprosthetic tricuspid valves in three patients with transvalvular device leads. Results: In all cases, the valve was successfully deployed and device lead function remained unchanged. In 1/3 cases with 6-month follow-up, device lead parameters remain unchanged and transcatheter valve-in-valve function remains satisfactory. Conclusions: Transcatheter tricuspid valve-in-valve is feasible in patients with pre-existing transvalvular devices leads. Further study is required to determine the long-term clinical implications of this treatment approach.

Original languageEnglish (US)
JournalCatheterization and Cardiovascular Interventions
DOIs
StateAccepted/In press - 2015

Fingerprint

Tricuspid Valve
Patents
Equipment and Supplies

Keywords

  • Percutaneous valve therapy
  • Structural heart disease intervention
  • Transcatheter valve implantation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Transcatheter tricuspid valve-in-valve in patents with transvalvular device leads. / Eleid, Mackram; Asirvatham, Samuel J; Cabalka, Allison K.; Hagler, Donald J.; Noseworthy, Peter; Taggart, Nathaniel W.; Rihal, Charanjit.

In: Catheterization and Cardiovascular Interventions, 2015.

Research output: Contribution to journalArticle

@article{4af9baabaf0840ae87a116c2cfb3948a,
title = "Transcatheter tricuspid valve-in-valve in patents with transvalvular device leads",
abstract = "Objective: To describe the effects of percutaneously implanted valve-in-valve in the tricuspid position for patients with pre-existing transvalvular device leads. Methods: In this case series, we describe implantation of the Melody valve and SAPIEN XT valve within dysfunctional bioprosthetic tricuspid valves in three patients with transvalvular device leads. Results: In all cases, the valve was successfully deployed and device lead function remained unchanged. In 1/3 cases with 6-month follow-up, device lead parameters remain unchanged and transcatheter valve-in-valve function remains satisfactory. Conclusions: Transcatheter tricuspid valve-in-valve is feasible in patients with pre-existing transvalvular devices leads. Further study is required to determine the long-term clinical implications of this treatment approach.",
keywords = "Percutaneous valve therapy, Structural heart disease intervention, Transcatheter valve implantation",
author = "Mackram Eleid and Asirvatham, {Samuel J} and Cabalka, {Allison K.} and Hagler, {Donald J.} and Peter Noseworthy and Taggart, {Nathaniel W.} and Charanjit Rihal",
year = "2015",
doi = "10.1002/ccd.25990",
language = "English (US)",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Transcatheter tricuspid valve-in-valve in patents with transvalvular device leads

AU - Eleid, Mackram

AU - Asirvatham, Samuel J

AU - Cabalka, Allison K.

AU - Hagler, Donald J.

AU - Noseworthy, Peter

AU - Taggart, Nathaniel W.

AU - Rihal, Charanjit

PY - 2015

Y1 - 2015

N2 - Objective: To describe the effects of percutaneously implanted valve-in-valve in the tricuspid position for patients with pre-existing transvalvular device leads. Methods: In this case series, we describe implantation of the Melody valve and SAPIEN XT valve within dysfunctional bioprosthetic tricuspid valves in three patients with transvalvular device leads. Results: In all cases, the valve was successfully deployed and device lead function remained unchanged. In 1/3 cases with 6-month follow-up, device lead parameters remain unchanged and transcatheter valve-in-valve function remains satisfactory. Conclusions: Transcatheter tricuspid valve-in-valve is feasible in patients with pre-existing transvalvular devices leads. Further study is required to determine the long-term clinical implications of this treatment approach.

AB - Objective: To describe the effects of percutaneously implanted valve-in-valve in the tricuspid position for patients with pre-existing transvalvular device leads. Methods: In this case series, we describe implantation of the Melody valve and SAPIEN XT valve within dysfunctional bioprosthetic tricuspid valves in three patients with transvalvular device leads. Results: In all cases, the valve was successfully deployed and device lead function remained unchanged. In 1/3 cases with 6-month follow-up, device lead parameters remain unchanged and transcatheter valve-in-valve function remains satisfactory. Conclusions: Transcatheter tricuspid valve-in-valve is feasible in patients with pre-existing transvalvular devices leads. Further study is required to determine the long-term clinical implications of this treatment approach.

KW - Percutaneous valve therapy

KW - Structural heart disease intervention

KW - Transcatheter valve implantation

UR - http://www.scopus.com/inward/record.url?scp=84928957897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928957897&partnerID=8YFLogxK

U2 - 10.1002/ccd.25990

DO - 10.1002/ccd.25990

M3 - Article

C2 - 25946058

AN - SCOPUS:84928957897

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

ER -